WIN 2016 highlights: Changing the understanding of cancer
1 Jul 2016
WIN 2016 highlights: Changing the understanding of cancer
Results of the MINDACT clinical trial
Systems thinking in the future of personalised medicine
New targets in personalised therapy for patients with lung cancer
A global perspective on infections related to cancer
MetAL trial for prostate cancer
Germline mutations influence risk and recovery throughout life
Telomeres, biology and cancer
Modelling ponatinib resistance in BCR-ABL1 cell lines
Genomic interrogation of tumour samples reveals essential targets
Breast and cervical cancer rates influenced by HRT, not contraceptive pill
Monitoring HPV vaccination program impact in Bhutan and Rwanda